A Novel Center-based Deep Contrastive Metric Learning Method for the Detection of Polymicrogyria in Pediatric Brain MRI
Lingfeng Zhang, Nishard Abdeen, Jochen Lang

TL;DR
This paper introduces a novel deep contrastive metric learning approach for automatic detection of polymicrogyria in pediatric brain MRI, achieving high recall on a challenging, small dataset to aid radiologists.
Contribution
It presents the first machine learning method specifically designed for detecting PMG in MRI, utilizing a new center-based contrastive loss and a customized deep learning architecture.
Findings
Achieved 92.01% recall in PMG detection
Developed a new anomaly detection framework for subtle brain MRI features
Created an open pediatric MRI dataset for PMG research
Abstract
Polymicrogyria (PMG) is a disorder of cortical organization mainly seen in children, which can be associated with seizures, developmental delay and motor weakness. PMG is typically diagnosed on magnetic resonance imaging (MRI) but some cases can be challenging to detect even for experienced radiologists. In this study, we create an open pediatric MRI dataset (PPMR) with PMG and controls from the Children's Hospital of Eastern Ontario (CHEO), Ottawa, Canada. The differences between PMG MRIs and control MRIs are subtle and the true distribution of the features of the disease is unknown. This makes automatic detection of cases of potential PMG in MRI difficult. We propose an anomaly detection method based on a novel center-based deep contrastive metric learning loss function (cDCM) which enables the automatic detection of cases of potential PMG. Additionally, based on our proposed loss…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMetabolism and Genetic Disorders · RNA modifications and cancer · Metabolomics and Mass Spectrometry Studies
